Cargando…
Pharmacists are initiators in palliative care for patients with rare diseases
The World Health Organization supports early delivery of palliative care as it reduces unnecessary hospital admissions and the inappropriate use of health care services. A community pharmacist can play a key role in advocating timely access to palliative care. Medication reconciliation must alert th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249311/ https://www.ncbi.nlm.nih.gov/pubmed/37291601 http://dx.doi.org/10.1186/s13023-023-02765-8 |
_version_ | 1785055533888176128 |
---|---|
author | Dooms, M. |
author_facet | Dooms, M. |
author_sort | Dooms, M. |
collection | PubMed |
description | The World Health Organization supports early delivery of palliative care as it reduces unnecessary hospital admissions and the inappropriate use of health care services. A community pharmacist can play a key role in advocating timely access to palliative care. Medication reconciliation must alert them to start communicating with the patient and/or his relatives about refocusing treatment and care as part of palliative and terminal care. Pharmaceutical activities for these patients include dispensing of devices and medicinal products, compounding personalized medication and participating as a member of the Palliative Support Team. Most of the several thousands of rare diseases are caused by genetic defects and up to now have no cure and a late diagnosis. |
format | Online Article Text |
id | pubmed-10249311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102493112023-06-09 Pharmacists are initiators in palliative care for patients with rare diseases Dooms, M. Orphanet J Rare Dis Position Statement The World Health Organization supports early delivery of palliative care as it reduces unnecessary hospital admissions and the inappropriate use of health care services. A community pharmacist can play a key role in advocating timely access to palliative care. Medication reconciliation must alert them to start communicating with the patient and/or his relatives about refocusing treatment and care as part of palliative and terminal care. Pharmaceutical activities for these patients include dispensing of devices and medicinal products, compounding personalized medication and participating as a member of the Palliative Support Team. Most of the several thousands of rare diseases are caused by genetic defects and up to now have no cure and a late diagnosis. BioMed Central 2023-06-08 /pmc/articles/PMC10249311/ /pubmed/37291601 http://dx.doi.org/10.1186/s13023-023-02765-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Position Statement Dooms, M. Pharmacists are initiators in palliative care for patients with rare diseases |
title | Pharmacists are initiators in palliative care for patients with rare diseases |
title_full | Pharmacists are initiators in palliative care for patients with rare diseases |
title_fullStr | Pharmacists are initiators in palliative care for patients with rare diseases |
title_full_unstemmed | Pharmacists are initiators in palliative care for patients with rare diseases |
title_short | Pharmacists are initiators in palliative care for patients with rare diseases |
title_sort | pharmacists are initiators in palliative care for patients with rare diseases |
topic | Position Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249311/ https://www.ncbi.nlm.nih.gov/pubmed/37291601 http://dx.doi.org/10.1186/s13023-023-02765-8 |
work_keys_str_mv | AT doomsm pharmacistsareinitiatorsinpalliativecareforpatientswithrarediseases |